"During treatment with 177Lu-PSMA-617, patients should be counseled to increase oral fluid intake and to void frequently to reduce bladder radiation exposure," writes Stephanie Trexler, PharmD, BCOP.
Stephanie Trexler, PharmD, BCOP
Advertisement
Articles by Stephanie Trexler, PharmD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Active Surveillance for Intermediate-risk Prostate Cancer, with Michael Leapman, MD, MHS
2
Christof Vulsteke, MD, PhD, breaks down findings, implications of KEYNOTE-905
3
The Significance of KEYNOTE-905 in Muscle-Invasive Bladder Cancer
4
Petros Grivas, MD, on the significance of a perioperative regimen for cisplatin-ineligible MIBC
5
